Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/49275
Full metadata record
DC FieldValueLanguage
dc.contributor.authorde Andrade, Gabriel Costa [UNIFESP]
dc.contributor.authorWertheimer, Christian
dc.contributor.authorEibl, Kirsten
dc.contributor.authorWolf, Armin
dc.contributor.authorKampik, Anselm
dc.contributor.authorRodrigues, Eduardo Buchele [UNIFESP]
dc.contributor.authorFarah, Michel Eid [UNIFESP]
dc.contributor.authorHaritoglou, Christos [UNIFESP]
dc.date.accessioned2019-01-21T10:29:34Z-
dc.date.available2019-01-21T10:29:34Z-
dc.date.issued2016
dc.identifierhttps://doi.org/10.1159/000452677
dc.identifier.citationOphthalmologica. Basel, v. 236, n. 4, p. 223-227, 2016.
dc.identifier.issn0030-3755
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/49275-
dc.description.abstractPurpose: The aim of this study was to access the safety profiles of 2 fusion proteins with anti-vascular endothelial growth factor action (ziv-aflibercept and aflibercept) on retinal pigment epithelium cells and Muller-Glia cells in culture by assessing cell viability post drug exposure. Methods: Primary human retinal pigment epithelium cells (pRPE) and Muller-Glia cells (Mio-M1) were exposed to the clinical standardized concentrations of ziv-aflibercept (25 mg/mL) and aflibercept (40 mg/mL). Progressively higher concentrations of NaCI (300, 500, 1,000, 1,500, 2,000, 5,000, and 10,000 mosm/kg) were also applied to cells to assess the possibility of potentiating hyperosmotic cytotoxity effect. The study was applied to measure pRPE and Mio-M1 viability by a tetrazolium dye-reduction assay (XTT). Results: Cell viability of both pRPE and Mio-M1 presented no significant changes after exposure of ziv-aflibercept and aflibercept. Progressive NaCI concentrations did not significantly alter cell viability. The exposure to the negative control of 75 mu L/mL of dimethyl sulfoxide showed significant reduction in cell viability. Conclusions: At clinical doses, neither ziv-aflibercept nor aflibercept caused any significant reduction in cell viability in vitro. Furthermore, injection solutions of NaCI with higher osmolality caused no significant reduction in cell viability. (C) 2017 S. Karger AG, Baselen
dc.format.extent223-227
dc.language.isoeng
dc.publisherTaylor & Francis Inc
dc.relation.ispartofOphthalmologica
dc.rightsAcesso restrito
dc.subjectZiv-Aflibercepten
dc.subjectAflibercepten
dc.subjectToxicityMacular Degenerationen
dc.subjectInhibitoren
dc.subjectGrowthen
dc.titleViability of primary human pigment epithelium cells and muller-glia cells after intravitreal ziv-aflibercept and aflibercepten
dc.typeArtigo
dc.description.affiliationDepartment of Ophthalmology, Federal University of São Paulo, Botucatu St 821, BR-04023062 Sao Paulo, Brazil
dc.description.affiliationDepartment of Ophthalmology, Ludwig-Maximilian-University, Munich, Germany
dc.description.affiliationUnifespDepartment of Ophthalmology, Federal University of São Paulo, Botucatu St 821, BR-04023062 Sao Paulo, Brazil
dc.identifier.doi10.1159/000452677
dc.description.sourceWeb of Science
dc.identifier.wosWOS:000392559700007
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.